Regenxbio (RGNX) Payables (2014 - 2026)
Regenxbio (RGNX) reported Payables of $15.55 million for Q2 2026, down 28.2% from $21.66 million a year earlier and down 26.7% from the prior quarter.
Powered by 
Analysis
Regenxbio (RGNX) Payables (2014 - 2026) Analysis & Trends
At the end of FY2025, Regenxbio posted Payables of $21.36 million, down 6.3% from FY2024.
- Payables has a five-year compound annual growth rate of 15.0% (FY2020 to FY2025).
- By year, Payables came in at $22.8 million in FY2024 (+0.1%), $22.79 million in FY2023 (-16.3%), $27.21 million in FY2022 (+139.0%) and $11.39 million in FY2021 (+7.2%).
- The Q2 2026 figure ranks as the lowest quarterly Payables since Q2 2023.
- Year over year, Payables gained in four of the last eight quarters, with an average decline of 3.3%.
- The high point for year-over-year Payables in five years was Q4 2022 (growth of 139.0%); the low point was Q1 2025 (a decline of 39.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $21.21 million (Q1 2026), $21.36 million (Q4 2025) and $22.27 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 5.79 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 34.43 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 7.17 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 2.95 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 934.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 4.07 Bn |
| 10 | Regenxbio | 418.33 Mn | -341.95 Mn | - | 15.55 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.55 Mn |
| Dec 31, 2025 | 21.36 Mn |
| Sep 30, 2025 | 22.27 Mn |
| Jun 30, 2025 | 21.66 Mn |
| Mar 31, 2025 | 19.04 Mn |
| Dec 31, 2024 | 22.80 Mn |
| Sep 30, 2024 | 19.52 Mn |
| Jun 30, 2024 | 16.36 Mn |
| Mar 31, 2024 | 31.36 Mn |
| Dec 31, 2023 | 22.79 Mn |
| Sep 30, 2023 | 21.86 Mn |
| Jun 30, 2023 | 11.64 Mn |
| Mar 31, 2023 | 23.28 Mn |
| Dec 31, 2022 | 27.21 Mn |
| Sep 30, 2022 | 25.21 Mn |
| Jun 30, 2022 | 16.99 Mn |
| Mar 31, 2022 | 24.71 Mn |
| Dec 31, 2021 | 11.39 Mn |
| Sep 30, 2021 | 19.85 Mn |
| Jun 30, 2021 | 9.35 Mn |
API Access
Regenxbio Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=RGNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "RGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=RGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();